Cost Consequence Analysis – CHB Treatment

Read this case study to know how the expert research solution team of BA Health armored the client with tools to sustain the market for Chronic Hepatitis B (CHB). Conducted across India, the quantitative study familiarized the client with cost consequence and cost-effectiveness analysis for competitor drugs in the treatment of the mentioned therapy area. Various forms of associated costs (both of the disease and available drugs) had been analyzed and then an MS Excel-based cost consequence model was designed to display cost difference for two different target drugs and view results on cost consequence for multiple age groups by gender. Additionally, a clinical gauge was designed and developed for bone mineral density (BMD) and Estimated glomerular filtration rate (eGFR). The outcome helped the stakeholder to convince key opinion leaders on the cost-effectiveness of the therapeutic drug on long-term use